About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Active substance
Terlipressin
Therapeutic area (MeSH)
Vasopressins
Procedure number
EMEA/H/A-31/1514
Regulatory outcome
Variation
DHPC type
Referral - Article 31
Referral name
Terlipressin-containing medicinal products indicated in the treatment of hepatorenal syndrome
Human ATC codes
H01BA04
Dissemination date
Glypressin, Terlipressin Acetate and Variquel

Share this page